{"rows":[{"id":4954,"title":"MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression","authors":"J Schneider, JP Cooper, S Davies, K Beltran","journal":"Value in Health","publication_date":"2022-06-24","publication_year":2022,"doi":"10.1016/j.jval.2022.04.1227","pubmed_id":null,"openalex_id":"https://openalex.org/W4283528627","source_url":"https://doi.org/10.1016/j.jval.2022.04.1227","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-07-04 06:51:57","bibtex":null,"source_record_id":"DOI:10.1016/j.jval.2022.04.1227","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jval.2022.04.1227","source_url":"https://doi.org/10.1016/j.jval.2022.04.1227","doi":"10.1016/j.jval.2022.04.1227","pmid":"","publication_date":"2022-06-24","importer_version":"2.1.3","text_redistributed":false}},{"id":1933,"title":"EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE","authors":"Sidovar Matthew, O'Connor Shane J., Orsini Lucinda","journal":"Value in Health","publication_date":"2026-06-01","publication_year":2026,"doi":"10.1016/j.jval.2026.03.422","pubmed_id":null,"openalex_id":"https://openalex.org/W7166071774","source_url":"https://doi.org/10.1016/j.jval.2026.03.422","substance_tags":"psilocybin","topic_tags":"Review Article","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:49:23","last_checked":"2026-08-09 08:28:47","bibtex":null,"source_record_id":"DOI:10.1016/j.jval.2026.03.422","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.jval.2026.03.422","source_url":"https://doi.org/10.1016/j.jval.2026.03.422","doi":"10.1016/j.jval.2026.03.422","pmid":"","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1930,"title":"EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION","authors":"Ziadi Yosr, Park Taehwan","journal":"Value in Health","publication_date":"2026-06-01","publication_year":2026,"doi":"10.1016/j.jval.2026.03.635","pubmed_id":null,"openalex_id":"https://openalex.org/W7166194446","source_url":"https://doi.org/10.1016/j.jval.2026.03.635","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:49:23","last_checked":"2026-08-09 08:28:47","bibtex":null,"source_record_id":"DOI:10.1016/j.jval.2026.03.635","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.jval.2026.03.635","source_url":"https://doi.org/10.1016/j.jval.2026.03.635","doi":"10.1016/j.jval.2026.03.635","pmid":"","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}}],"total":3,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Value in Health","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}